TopFunds

Align Technology

NASDAQ: ALGN

Stock price

148.95 USD

(-76.14%) 5 years

Health Care SuppliesMedical - Devices

Financial Performance

Share

5Y price score: (117)

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 74.7%

DATE RANGE:

%

ㅤ

  • Earnings per share

  • Free cash flow per share

  • Stock price

Time scale:

By default your notes are visible only to you.

130.2

52-week range

200.4

148.945

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

7.7 %

Dividend Yield TTM

-

Market cap $

$ 10,581

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

21.6

Price / Book TTM

2.5

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

40.5

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

12.8 %

(76.2) %

74.7 %

Free cash flow per share growth

52.7 %

5.6 %

198.7 %

Earnings per share growth

143.6 %

(74.8) %

219.2 %

Founded: 1,997

Employees: 21,200

Business Summary:Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Q&A

SEARCH
Get answers on financials, industry, fundamentals or other questions.

Contribute

By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more

VIEW ALL Q&A

Contribute or ask questions about business following TopFunds community guidelines

Fair Value Reference Estimate

Latest Earnings Call Takeaways

2026 Q3 (Oct 28, 2026)

1) Q3 2026 Performance Overview
- Align Technology reported Q3 2026 revenue of $1.015 billion, a 1.9% increase YoY (2.4% at constant currency). - Clear Aligner shipments reached 691,000, up 6.6% YoY, meeting the high end of expectations. - Systems and Services revenue was $175.5 million, down 7.6% YoY, reflecting a shift towards lower-priced scanner configurations. - Non-GAAP gross margin was 70.4%, slightly below expectations due to higher transportation costs and lower Clear Aligner ASP.

2) Strategic Initiatives and Growth Opportunities
- Align is focusing on increasing utilization among orthodontists and expanding Invisalign adoption among general practitioners (GPs). - The company launched the "SHIFT Happens" campaign to boost adult consumer awareness and conversion. - Significant growth in younger patient shipments, particularly in international markets, with double-digit increases in APAC and EMEA. - The introduction of the Zero Additional Aligner offering has seen triple-digit volume growth YoY.

3) Regional Performance Insights
- In the Americas, Clear Aligner shipments rose approximately 1.5% YoY, with North America seeing its first year-over-year growth in orthodontic shipments in six quarters. - Latin America experienced strong double-digit growth across channels, while EMEA also reported double-digit growth, particularly among orthodontists and GPs. - APAC saw a 16% increase in retail shipments YoY, driven by strong demand for younger patient treatments.

4) Challenges and Market Headwinds
- The broader market remains challenging, with consumer spending on discretionary healthcare under pressure. - The company anticipates continued softness in consumer demand, impacting guidance for Q4 and fiscal 2026. - Systems and Services revenue outlook for Q4 is lower than previous guidance due to ongoing shifts towards lower-priced scanners and flexible acquisition models.

5) Guidance and Future Outlook
- For Q4 2026, Align expects worldwide revenues between $1 billion and $1.020 billion, with Clear Aligner volume growth projected at low single digits YoY. - Fiscal 2026 revenue guidance is set at approximately $4.11 billion to $4.13 billion, with Clear Aligner growth expected at 5% to 6% YoY. - The company plans to repurchase approximately $500 million of common stock in 2026, reflecting confidence in long-term value.

Bottom line: Align Technology is navigating a challenging market environment while delivering solid Q3 results and maintaining growth in Clear Aligner shipments. The company is focused on strategic initiatives to enhance utilization and expand its digital platform, although it faces headwinds from consumer spending pressures. The outlook for 2026 remains cautiously optimistic, with continued emphasis on profitability and shareholder returns.

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Align Technology — Financial Overview, Stock Price, Market Cap

Align Technology is a company. Founded in 1997. As of October 30, 2026, the company's market capitalization is $10581038426 with a current stock price of $148.95.